merck springworks - Search News

Merck KGaA, SpringWorks

Reuters on MSN · 2h

Germany's Merck in advanced talks to acquire US biotech firm SpringWorks

Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks Therapeutics. Merck, in a statement, said its negotiations to buy SpringWorks are ongoing,

Merck KGaA Courts Cancer Biotech SpringWorks for Potential Buyout

Following an initial report from Reuters, Merck KGaA confirmed that it is in talks with SpringWorks for a potential acquisition, though details of its offer have yet to be revealed.

Bloomberg L.P. · 1d

Merck KGaA in Talks to Buy SpringWorks Therapeutics

Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare diseases drugmaker soaring.

UPDATE: Merck KGaA sets its sights on acquisition of Ogsiveo maker SpringWorks

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...

Merck confirms its interest in buying SpringWorks

Merck said in a brief statement that discussions are "advanced" but noted that "critical conditions have yet to be met" ...

2h

SpringWorks Therapeutics price target raised to $65 from $55 at BofA

BofA analyst Alec Stranahan raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $65 from $55 and keeps a Buy rating on the ...

11hon MSN

Merck KGaA verhandelt Milliardendeal mit US-Tumorspezialisten

Die Merck KGaA befindet sich in fortgeschrittenen Verhandlungen zum Kauf des amerikanischen Krebsspezialisten SpringWorks ...

23h

SpringWorks Therapeutics may be worth around $77 a share in a takeover - analyst

SpringWorks Therapeutics (SWTX) may be acquired by Merck KGaA for $77 per share, representing a potential premium of 92% ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results